Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022

doi:10.1001/jama.2023.6028

. 2023 Jun 6;329(21):1877-1879.

doi: 10.1001/jama.2023.6028.

Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022

Farnoosh Nik-Ahd¹, Amanda De Hoedt², Christi Butler¹, Jennifer T Anger³, Peter R Carroll¹, Matthew R Cooperberg¹, Stephen J Freedland⁴

Affiliations

¹ Department of Urology, University of California, San Francisco.
² Division of Urology, Veterans Affairs Health Care System, Durham, North Carolina.
³ Department of Urology, University of California, San Diego.
⁴ Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California.

PMID: 37119522
PMCID: PMC10148974
DOI: 10.1001/jama.2023.6028

Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022

Farnoosh Nik-Ahd et al. JAMA. 2023.

. 2023 Jun 6;329(21):1877-1879.

doi: 10.1001/jama.2023.6028.

Authors

Farnoosh Nik-Ahd¹, Amanda De Hoedt², Christi Butler¹, Jennifer T Anger³, Peter R Carroll¹, Matthew R Cooperberg¹, Stephen J Freedland⁴

Affiliations

¹ Department of Urology, University of California, San Francisco.
² Division of Urology, Veterans Affairs Health Care System, Durham, North Carolina.
³ Department of Urology, University of California, San Diego.
⁴ Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California.

PMID: 37119522
PMCID: PMC10148974
DOI: 10.1001/jama.2023.6028

No abstract available

Plain language summary

This case series investigates the rate of prostate cancer diagnoses among transgender women treated in the Veterans Affairs health system.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Cooperberg reported serving as an advisor for Astellas, AstraZeneca, Janssen, Merck, Veracyte, Bayer, Dendreon, Exact Sciences, Exosome, Verana Health, and ConcertAI outside the submitted work. No other disclosures were reported.

Cited by

Prostate cancer in transgender women - challenges in research and clinical care.
Nik-Ahd F, Anger JT, Cooperberg MR, Freedland SJ. Nik-Ahd F, et al. Nat Rev Urol. 2024 Nov 4. doi: 10.1038/s41585-024-00966-9. Online ahead of print. Nat Rev Urol. 2024. PMID: 39496778 No abstract available.
"Prostatectomy after gender-affirming vaginoplasty for a transgender woman with prostate cancer".
Blasdel G, Borah L, Navarrete R, Howland R, Kuzon WM Jr, Montgomery JS. Blasdel G, et al. Urol Case Rep. 2024 Aug 6;56:102819. doi: 10.1016/j.eucr.2024.102819. eCollection 2024 Sep. Urol Case Rep. 2024. PMID: 39220296 Free PMC article.
The Landscape of Care for Women Veterans with Cancer: An Evidence Map.
Pace R, Goldstein KM, Williams AR, Clayton-Stiglbauer K, Meernik C, Shepherd-Banigan M, Chawla N, Moss H, Skalla LA, Colonna S, Kelley MJ, Zullig LL. Pace R, et al. J Gen Intern Med. 2024 Sep;39(12):2300-2316. doi: 10.1007/s11606-024-08903-7. Epub 2024 Jul 4. J Gen Intern Med. 2024. PMID: 38965201
Prostate Cancer Screening Uptake in Transgender Women.
Kalavacherla S, Riviere P, Kalavacherla S, Anger JT, Murphy JD, Rose BS. Kalavacherla S, et al. JAMA Netw Open. 2024 Feb 5;7(2):e2356088. doi: 10.1001/jamanetworkopen.2023.56088. JAMA Netw Open. 2024. PMID: 38353948 Free PMC article.
Incidence of prostate cancer in transgender women in the US: a large database analysis.
Loria M, Gilbert D, Tabernacki T, Maravillas MA, McNamara M, Gupta S, Mishra K. Loria M, et al. Prostate Cancer Prostatic Dis. 2024 Feb 7. doi: 10.1038/s41391-024-00804-4. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38326392

See all "Cited by" articles

References

1. Deebel NA, Morin JP, Autorino R, Vince R, Grob B, Hampton LJ. Prostate cancer in transgender women: incidence, etiopathogenesis, and management challenges. Urology. 2017;110:166-171. doi:10.1016/j.urology.2017.08.032 - DOI - PubMed
1. Nik-Ahd F, Waller J, De Hoedt AM, et al. . Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system’s electronic medical record? J Sex Med. 2023;qdac033. doi:10.1093/jsxmed/qdac033 - DOI - PubMed
1. Malkowicz SB. The role of diethylstilbestrol in the treatment of prostate cancer. Urology. 2001;58(2)(suppl 1):108-113. doi:10.1016/S0090-4295(01)01252-3 - DOI - PubMed
1. Bryant AK, Lee KM, Alba PR, et al. . Association of prostate-specific antigen screening rates with subsequent metastatic prostate cancer incidence at US Veterans Health Administration facilities. JAMA Oncol. 2022;8(12):1747-1755. doi:10.1001/jamaoncol.2022.4319 - DOI - PMC - PubMed
1. Sterling J, Garcia MM. Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model. Transl Androl Urol. 2020;9(6):2771-2785. doi:10.21037/tau-20-954 - DOI - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Deebel NA, Morin JP, Autorino R, Vince R, Grob B, Hampton LJ. Prostate cancer in transgender women: incidence, etiopathogenesis, and management challenges. Urology. 2017;110:166-171. doi:10.1016/j.urology.2017.08.032 - DOI - PubMed

[2] Deebel NA, Morin JP, Autorino R, Vince R, Grob B, Hampton LJ. Prostate cancer in transgender women: incidence, etiopathogenesis, and management challenges. Urology. 2017;110:166-171. doi:10.1016/j.urology.2017.08.032 - DOI - PubMed

[3] Nik-Ahd F, Waller J, De Hoedt AM, et al. . Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system’s electronic medical record? J Sex Med. 2023;qdac033. doi:10.1093/jsxmed/qdac033 - DOI - PubMed

[4] Nik-Ahd F, Waller J, De Hoedt AM, et al. . Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system’s electronic medical record? J Sex Med. 2023;qdac033. doi:10.1093/jsxmed/qdac033 - DOI - PubMed

[5] Malkowicz SB. The role of diethylstilbestrol in the treatment of prostate cancer. Urology. 2001;58(2)(suppl 1):108-113. doi:10.1016/S0090-4295(01)01252-3 - DOI - PubMed

[6] Malkowicz SB. The role of diethylstilbestrol in the treatment of prostate cancer. Urology. 2001;58(2)(suppl 1):108-113. doi:10.1016/S0090-4295(01)01252-3 - DOI - PubMed

[7] Bryant AK, Lee KM, Alba PR, et al. . Association of prostate-specific antigen screening rates with subsequent metastatic prostate cancer incidence at US Veterans Health Administration facilities. JAMA Oncol. 2022;8(12):1747-1755. doi:10.1001/jamaoncol.2022.4319 - DOI - PMC - PubMed

[8] Bryant AK, Lee KM, Alba PR, et al. . Association of prostate-specific antigen screening rates with subsequent metastatic prostate cancer incidence at US Veterans Health Administration facilities. JAMA Oncol. 2022;8(12):1747-1755. doi:10.1001/jamaoncol.2022.4319 - DOI - PMC - PubMed

[9] Sterling J, Garcia MM. Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model. Transl Androl Urol. 2020;9(6):2771-2785. doi:10.21037/tau-20-954 - DOI - PMC - PubMed

[10] Sterling J, Garcia MM. Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model. Transl Androl Urol. 2020;9(6):2771-2785. doi:10.21037/tau-20-954 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022

Affiliations

Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022

Authors

Affiliations

Plain language summary

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Plain language summary

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Medical